240 related articles for article (PubMed ID: 36525138)
1. GDF15 negatively regulates chemosensitivity via TGFBR2-AKT pathway-dependent metabolism in esophageal squamous cell carcinoma.
Du Y; Ma Y; Zhu Q; Fu Y; Li Y; Zhang Y; Li M; Feng F; Yuan P; Wang X
Front Med; 2023 Feb; 17(1):119-131. PubMed ID: 36525138
[TBL] [Abstract][Full Text] [Related]
2. GDF15 derived from both tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression via Akt and Erk pathways.
Urakawa N; Utsunomiya S; Nishio M; Shigeoka M; Takase N; Arai N; Kakeji Y; Koma Y; Yokozaki H
Lab Invest; 2015 May; 95(5):491-503. PubMed ID: 25730371
[TBL] [Abstract][Full Text] [Related]
3. Growth Differentiation Factor 15 Promotes Progression of Esophageal Squamous Cell Carcinoma via TGF-β Type II Receptor Activation.
Okamoto M; Koma YI; Kodama T; Nishio M; Shigeoka M; Yokozaki H
Pathobiology; 2020; 87(2):100-113. PubMed ID: 31896114
[TBL] [Abstract][Full Text] [Related]
4. eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma.
Liu T; Li R; Zhao H; Deng J; Long Y; Shuai MT; Li Q; Gu H; Chen YQ; Leng AM
Oncotarget; 2016 Oct; 7(41):66851-66864. PubMed ID: 27588477
[TBL] [Abstract][Full Text] [Related]
5. RUNX3 reverses cisplatin resistance in esophageal squamous cell carcinoma via suppression of the protein kinase B pathway.
Li DJ; Shi M; Wang Z
Thorac Cancer; 2016 Sep; 7(5):570-580. PubMed ID: 27766776
[TBL] [Abstract][Full Text] [Related]
6. CCT4 knockdown enhances the sensitivity of cisplatin by inhibiting glycolysis in human esophageal squamous cell carcinomas.
Fang J; Ma Y; Li Y; Li J; Zhang X; Han X; Ma S; Guan F
Mol Carcinog; 2022 Nov; 61(11):1043-1055. PubMed ID: 36102200
[TBL] [Abstract][Full Text] [Related]
7. Methylation silencing of TGF-β receptor type II is involved in malignant transformation of esophageal squamous cell carcinoma.
Ma Y; He S; Gao A; Zhang Y; Zhu Q; Wang P; Yang B; Yin H; Li Y; Song J; Yue P; Li M; Zhang D; Liu Y; Wang X; Guo M; Jiao Y
Clin Epigenetics; 2020 Feb; 12(1):25. PubMed ID: 32046777
[TBL] [Abstract][Full Text] [Related]
8. Tumor-associated macrophage (TAM)-secreted CCL22 confers cisplatin resistance of esophageal squamous cell carcinoma (ESCC) cells via regulating the activity of diacylglycerol kinase α (DGKα)/NOX4 axis.
Chen J; Zhao D; Zhang L; Zhang J; Xiao Y; Wu Q; Wang Y; Zhan Q
Drug Resist Updat; 2024 Mar; 73():101055. PubMed ID: 38387281
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma.
Zuo J; Zhao M; Fan Z; Liu B; Wang Y; Li Y; Lv P; Xing L; Zhang X; Shen H
Thorac Cancer; 2020 Mar; 11(3):738-747. PubMed ID: 32012470
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of fibulin-4 inhibits autophagy and promotes the sensitivity of esophageal squamous cell carcinoma cells to apatinib by activating the Akt-mTOR signaling pathway.
Chen X; Wang J; Song L; Yu Y; Shi M; Jiang W; Liu X; He X
Thorac Cancer; 2022 Sep; 13(18):2592-2605. PubMed ID: 35950373
[TBL] [Abstract][Full Text] [Related]
11. Reticulocalbin3: A Ca
Cai R; Wang P; Zhao X; Lu X; Deng R; Wang X; Hong C; Lin J
Cancer Sci; 2022 Oct; 113(10):3593-3607. PubMed ID: 35839283
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of frizzled-7 inhibits cell growth and metastasis and promotes chemosensitivity of esophageal squamous cell carcinoma cells by inhibiting Wnt signaling.
Liu X; Yan Y; Ma W; Wu S
Biochem Biophys Res Commun; 2017 Aug; 490(3):1112-1118. PubMed ID: 28669726
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
[TBL] [Abstract][Full Text] [Related]
14. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
Yu T; Cao R; Li S; Fu M; Ren L; Chen W; Zhu H; Zhan Q; Shi R
BMC Cancer; 2015 Jan; 15():29. PubMed ID: 25637514
[TBL] [Abstract][Full Text] [Related]
15. A dual mTORC1 and mTORC2 inhibitor shows antitumor activity in esophageal squamous cell carcinoma cells and sensitizes them to cisplatin.
Huang Y; Xi Q; Chen Y; Wang J; Peng P; Xia S; Yu S
Anticancer Drugs; 2013 Oct; 24(9):889-98. PubMed ID: 23838676
[TBL] [Abstract][Full Text] [Related]
16. Wild-type phosphatase and tensin homolog deleted on chromosome 10 improved the sensitivity of cells to rapamycin through regulating phosphorylation of Akt in esophageal squamous cell carcinoma.
Lu Z; Wang J; Zheng Y; Yang S; Liu M; Chen X; Wang C; Hou G
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26725440
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the Long Noncoding RNA FOXD2-AS1 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma Through the miR-195/Akt/mTOR Axis.
Liu H; Zhang J; Luo X; Zeng M; Xu L; Zhang Q; Liu H; Guo J; Xu L
Oncol Res; 2020 Feb; 28(1):65-73. PubMed ID: 31558183
[TBL] [Abstract][Full Text] [Related]
18. Apollon modulates chemosensitivity in human esophageal squamous cell carcinoma.
Zhang S; Tang W; Weng S; Liu X; Rao B; Gu J; Chen S; Wang Q; Shen X; Xue R; Dong L
Oncotarget; 2014 Aug; 5(16):7183-97. PubMed ID: 25216531
[TBL] [Abstract][Full Text] [Related]
19. Silencing HMGN5 suppresses cell growth and promotes chemosensitivity in esophageal squamous cell carcinoma.
Liu X; Ma W; Yan Y; Wu S
J Biochem Mol Toxicol; 2017 Dec; 31(12):. PubMed ID: 28914995
[TBL] [Abstract][Full Text] [Related]
20. FAT1 downregulation enhances stemness and cisplatin resistance in esophageal squamous cell carcinoma.
Zhai Y; Shan C; Zhang H; Kong P; Zhang L; Wang Y; Hu X; Cheng X
Mol Cell Biochem; 2022 Dec; 477(12):2689-2702. PubMed ID: 35606602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]